Assessment of cardiac sympathetic nerve integrity with positron emission tomography

Nuclear Medicine and Biology - Tập 28 - Trang 541-559 - 2001
David M Raffel1, Donald M Wieland1
1Division of Nuclear Medicine, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109-0552, USA

Tài liệu tham khảo

Agostini, 2000, Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy, J. Nucl. Med., 41, 845

Allman, 1993, Noninvasive assessment of cardiac diabetic neuropathy by C-11 hydroxyephedrine and positron emission tomography, J. Am. Coll. Cardiol., 22, 1425, 10.1016/0735-1097(93)90553-D

Al-Sheikh, 1999, Cardiac sympathetic denervation after transmyocardial laser revascularization, Circulation, 100, 135, 10.1161/01.CIR.100.2.135

Armour, 1998, Myocardial ischæmia and the cardiac nervous system, Cardiovasc. Res., 41, 41, 10.1016/S0008-6363(98)00252-1

Barron, 1996, Autonomic nervous system and sudden cardiac death, J. Am. Coll. Cardiol., 27, 1053, 10.1016/0735-1097(95)00615-X

Bengel, 1999, Serial assessment of sympathetic reinnervation after orthotopic heart transplantation, Circulation, 99, 1866, 10.1161/01.CIR.99.14.1866

Berne, 2001

Boyd, 1999, Noradrenaline transporter gene transfer for radiation cell kill by 131I meta-iodobenzylguanidine, Gene Ther, 6, 1147, 10.1038/sj.gt.3300905

Broadley, 1996

Burgen, 1965, The inhibition of noradrenaline uptake by sympathomimetic amines in the rat isolated heart, Br. J. Pharmacol., 25, 34

Chakraborty, 1993, High yield synthesis of high specific activity R-(−)-[11C]epinephrine for routine PET studies in humans, Nucl. Med. Biol., 20, 939, 10.1016/0969-8051(93)90094-B

Dae, 1995, Scintigraphy of myocardial innervation with metaiodobenzylguanidine (MIBG), J. Nucl. Cardiol., 2, 151, 10.1016/S1071-3581(95)80026-3

DeGrado, 1993, Myocardial kinetics of carbon-11-meta-hydroxyephedrine, J. Nucl. Med., 34, 1287

DeGrado, 1998, Effects of specific activity on meta-[123I]iodobenzylguanidine kinetics in isolated rat heart, Nucl. Med. Biol., 25, 59, 10.1016/S0969-8051(97)00158-3

del Rosario, 1995, Synthesis of [11C](−)-α-α-dideutero-phenylephrine for in vivo kinetic isotope studies, J. Labeled Compds. Radiopharm., 36, 625, 10.1002/jlcr.2580360703

del Rosario, 1996, Synthesis and preliminary evaluation of [C-11] phenylephrine for mapping heart neuronal function, Nucl. Med. Biol., 23, 611, 10.1016/0969-8051(96)00057-1

Di Carli, 1997, Effects of cardiac sympathetic innervation on coronary blood flow, N. Engl. J. Med., 336, 1028, 10.1056/NEJM199704243361703

Ding, 1991, Synthesis of high specific activity (+) and (−)-6-[18F]fluoronorepinephrine via the nucleophilic aromatic substitution reaction, J. Med. Chem., 34, 767, 10.1021/jm00106a043

Ding, 1991, Synthesis of high specific activity 6-[18F]fluorodopamine for PET studies of sympathetic nervous tissue, J. Med. Chem., 34, 861, 10.1021/jm00106a055

Ding, 1995, Mechanistic positron emission tomography studies of 6-[18F]fluorodopamine in living baboon heart, J. Neurochem., 65, 682, 10.1046/j.1471-4159.1995.65020682.x

Ermert, 1998, 4-[18F]Fluorometaraminol, Eur. J. Nucl. Med., 25, 881

Esler, 1993, Clinical application of noradrenaline spillover methodology, Pharmacology & Toxicology, 73, 243, 10.1111/j.1600-0773.1993.tb00579.x

Ewing, 1996, Diabetic autonomic neuropathy and the heart, Diabetes Res. Clin. Pract., 30, 31, 10.1016/S0168-8227(96)80036-2

Farde, 1994, Positron emission tomography shows high specific uptake of racemic carbon-11 labelled norepinephrine in the primate heart, Eur. J. Nucl. Med., 21, 345, 10.1007/BF00947971

Fowler, 1974, A new rapid synthesis of carbon-11 labeled norepinephrine hydrochloride, J. Med. Chem., 17, 246, 10.1021/jm00248a025

Fowler, 1995, Selective reduction of radiotracer trapping by deuterium substitution, J. Nucl. Med., 36, 1255

Fuller, 1981, Formation of alpha-methylnorepinephrine as a metabolite of metaraminol in guinea pigs, Biochem. Pharmacol., 30, 2831, 10.1016/0006-2952(81)90422-6

Gabella, 1995, Fine structure of post-ganglionic nerve fibres and autonomic neuroeffector junctions, 1

Garg, 1994, Synthesis and preliminary evaluation of para- and meta-[18F]fluorobenzylguanidine, Nucl. Med. Biol., 21, 97, 10.1016/0969-8051(94)90135-X

Gill, 1993, Asymmetry of cardiac [123I]meta-iodobenzylguanidine scans in patients with ventricular tachycardia and a “clinically normal” heart, Br. Heart J., 69, 6, 10.1136/hrt.69.1.6

Glowniak, 1995, Cardiac studies with metaiodobenzylguanidine, J. Nucl. Med., 36, 2133

Goldstein, 1990, Positron emission tomographic imaging of cardiac sympathetic innervation and function, Circulation, 81, 1606, 10.1161/01.CIR.81.5.1606

Goldstein, 1997, Sympathetic cardioneuropathy in dysautonomias, N. Engl. J. Med., 336, 696, 10.1056/NEJM199703063361004

Goldstein, 2000, Cardiac sympathetic denervation in Parkinson disease, Ann. Intern. Med., 133, 338, 10.7326/0003-4819-133-5-200009050-00009

Graefe, 1981, The disposition of 3H-(−)-noradrenaline in the perfused cat and rabbit heart, Naunyn-Schmiedeberg’s Arch. Pharmacol., 318, 71, 10.1007/BF00508829

Grassi, 1999, How to assess sympathetic activity in humans, J. Hypertens., 17, 719, 10.1097/00004872-199917060-00001

Hartmann, 1999, Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy, Heart, 81, 262, 10.1136/hrt.81.3.262

Henderson, 1988, Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy, Circulation, 78, 1192, 10.1161/01.CIR.78.5.1192

Inoue, 1985, Radioactive N,N-dimethylphenylethylamine, J. Neurochem., 44, 210, 10.1111/j.1471-4159.1985.tb07132.x

Iversen, 1965, The uptake of catechol amines at high perfusion concentrations in the rat isolated heart, Br. J. Pharmacol., 25, 18

Jayachandran, 2000, Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation, Circulation, 101, 1185, 10.1161/01.CIR.101.10.1185

Kingwell, 1994, Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure, Circulation, 90, 234, 10.1161/01.CIR.90.1.234

Kirk, 1976, Photochemistry of diazonium salts. 4. Synthesis of ring-fluorinated tyramines and dopamines, J. Org. Chem., 41, 2373, 10.1021/jo00876a004

Langer, 2000, High specific radioactivity (1R,2S)-4-[18F]fluorometaraminol, Nucl. Med. Biol., 27, 233, 10.1016/S0969-8051(00)00082-2

Li, 2000, Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy, J. Am. Coll. Cardiol., 35, 1867, 10.1016/S0735-1097(00)00626-4

Loc’h, 1994, Preparation and pharmacological characterization of 76Br-meta-bromobenzylguanidine (76Br-MBBG), Nucl. Med. Biol., 21, 49, 10.1016/0969-8051(94)90128-7

March, 1992

Melon, 1994, Imaging of cardiac neuronal function after cocaine exposure using carbon-11 hydroxyephedrine and positron emission tomography, J. Am. Coll. Cardiol., 23, 1693, 10.1016/0735-1097(94)90677-7

Mislankar, 1988, 6-[18F]Fluorometaraminol, J. Med. Chem., 31, 362, 10.1021/jm00397a016

Münch, 2000, Evaluation of sympathetic nerve terminals with [11C]epinephrine and [11C]hydroxyephedrine and positron emission tomography, Circulation, 101, 516, 10.1161/01.CIR.101.5.516

Någren, 1994, Selective synthesis of racemic 1-11C-labeled norepinephrine, octopamine, norphenylephrine, and phenylethanolamine using [11C]nitromethane, Appl. Radiat. Isot., 45, 515, 10.1016/0969-8043(94)90117-1

Någren, 1996, [11C]metaraminol, a false neurotransmitter, Nucl. Med. Biol., 23, 221, 10.1016/0969-8051(95)02050-0

Nguyen, 1997, Myocardial kinetics of C-11 epinephrine in the isolated working rat heart, J. Nucl. Med., 38, 780

Packer, 1992, The neurohormonal hypothesis, J. Am. Coll. Cardiol., 20, 248, 10.1016/0735-1097(92)90167-L

Raffel, 1998, Kinetics of the norepinephrine analog [Br-76]-meta-bromobenzylguanidine in isolated working rat heart, Nucl. Med. Biol., 25, 1, 10.1016/S0969-8051(97)00141-8

Raffel, 1996, Clinical evaluation of carbon-11-phenylephrine, J. Nucl. Med., 37, 1923

Raffel, 1999, Influence of vesicular storage and monoamine oxidase activity on [11C]phenylephrine kinetics, J. Nucl. Med., 40, 323

Romanenko, 1998, Determination of transport parameters of permeant substrates of the vesicular amine transporter, Anal. Biochem., 257, 127, 10.1006/abio.1997.2546

Rosell, 1964, Release of tritiated epinephrine following sympathetic nerve stimulation, Nature, Lond, 201, 301, 10.1038/201301a0

Rosenspire, 1990, Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine, J. Nucl. Med., 31, 1328

Satoh, 1999, Loss of 123I-MIBG uptake by the heart in Parkinson’s disease, J. Nucl. Med., 40, 371

Schoeps, 1993, Preparation of [1-11C]dopamine, [1-11C]p-tyramine and [1-11C]m-tyramine. Autoradiography and PET examination of [1-11C]dopamine in primates, Nucl. Med. Biol., 20, 669, 10.1016/0969-8051(93)90038-V

Schwaiger, 1991, Evidence of regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography, J. Clin. Invest., 87, 1681, 10.1172/JCI115185

Schwaiger, 1992, Noninvasive evaluation of the cardiac sympathetic nervous system with positron emission tomography, 231

Shulkin, 1992, PET scanning with hydroxyephedrine, J. Nucl. Med., 33, 1125

Sisson, 1999, Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy, Am. J. Clin. Oncol., 22, 364, 10.1097/00000421-199908000-00008

Stevens, 1998, Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy, J. Am. Coll. Cardiol., 31, 1575, 10.1016/S0735-1097(98)00128-4

Stevens, 1998, Cardiac sympathetic dysinnervation in diabetes, Circulation, 98, 961, 10.1161/01.CIR.98.10.961

Stevens, 1999, Regression and progression of cardiac sympathetic dysinnervation complicating diabetes, Metabolism, 48, 92, 10.1016/S0026-0495(99)90016-1

Takatsu, 2000, Cardiac sympathetic denervation from the early stage of Parkinson’s disease, J. Nucl. Med., 41, 71

Tepmongkol, 1999, 131I MIBG therapy in neuroblastoma, Med. Pediatr. Oncol., 32, 427, 10.1002/(SICI)1096-911X(199906)32:6<427::AID-MPO6>3.0.CO;2-T

Tominaga, 1987, [N-13]-β-Phenethylamine ([N-13]PEA), Biochem. Pharmac., 36, 3671

Überfuhr, 2000, Incomplete sympathetic reinnervation of the orthotopically transplanted human heart, Eur. J. Cardiothorac. Surg., 17, 161, 10.1016/S1010-7940(99)00367-X

Ungerer, 1998, Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart, Circulation, 97, 174, 10.1161/01.CIR.97.2.174

Valette, 1993, 76Br-metabromobenzylguanidine, J. Nucl. Med., 34, 1739

Walter, 1986, Permeability of small nonelectrolytes through lipid bilayer membranes, J. Membrane. Biol., 90, 207, 10.1007/BF01870127

White, 1984, Species differences in monoamine oxidase-A and -B as revealed by sensitivity to trypsin, Life Sci, 35, 827, 10.1016/0024-3205(84)90407-7

Wieland, 1993, Comparison of true and false neurotransmitters in the heart, J. Nucl. Med., 34, 123P

Wolpers, 1991, 11C-hydroxyephedrine as marker for neuronal catecholamine retention in reperfused canine myocardium, Coronary Artery Disease, 2, 923

Yu, 1986, Stereospecific deuterium substitution at the α-carbon position of dopamine and its effects on oxidative deamination catalyzed by MAO-A and MAO-B from different tissues, Biochem. Pharmac., 35, 1027, 10.1016/0006-2952(86)90094-8

Ziegler, 1996, Assessment of myocardial reinnervation in cardiac transplants by positron emission tomography, Clin. Sci., 91, 126, 10.1042/cs0910126supp